These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 30905614)
1. A follow-up report on potential drug interactions with clementines: Two single case experiments show no effect on CYP3A-dependent midazolam clearance. Hohmann N; Mikus G; Haefeli WE; Schwenger V; Gattuso G; Barreca D; Weiss J Eur J Pharm Sci; 2019 May; 133():54-58. PubMed ID: 30905614 [TBL] [Abstract][Full Text] [Related]
2. Nobiletin, sinensetin, and tangeretin are the main perpetrators in clementines provoking food-drug interactions in vitro. Weiss J; Gattuso G; Barreca D; Haefeli WE Food Chem; 2020 Jul; 319():126578. PubMed ID: 32187570 [TBL] [Abstract][Full Text] [Related]
3. Clementine juice has the potential for drug interactions - In vitro comparison with grapefruit and mandarin juice. Theile D; Hohmann N; Kiemel D; Gattuso G; Barreca D; Mikus G; Haefeli WE; Schwenger V; Weiss J Eur J Pharm Sci; 2017 Jan; 97():247-256. PubMed ID: 27890698 [TBL] [Abstract][Full Text] [Related]
4. Effect of Low-Furanocoumarin Hybrid Grapefruit Juice Consumption on Midazolam Pharmacokinetics. Kawaguchi-Suzuki M; Nasiri-Kenari N; Shuster J; Gmitter FG; Cancalon P; de Oliveria F; Kight J; Handberg EM; Pepine CJ; Frye RF; Cooper-DeHoff RM J Clin Pharmacol; 2017 Mar; 57(3):305-311. PubMed ID: 27503364 [TBL] [Abstract][Full Text] [Related]
5. In vivo CYP3A activity is significantly lower in cyclosporine-treated as compared with tacrolimus-treated renal allograft recipients. de Jonge H; de Loor H; Verbeke K; Vanrenterghem Y; Kuypers DR Clin Pharmacol Ther; 2011 Sep; 90(3):414-22. PubMed ID: 21753749 [TBL] [Abstract][Full Text] [Related]
6. Interaction of Citrus Juices with Cyclosporine: Systematic Review and Meta-Analysis. Sridharan K; Sivaramakrishnan G Eur J Drug Metab Pharmacokinet; 2016 Dec; 41(6):665-673. PubMed ID: 27278683 [TBL] [Abstract][Full Text] [Related]
7. Effects of Grapefruit and Pomegranate Juices on the Pharmacokinetic Properties of Dapoxetine and Midazolam in Healthy Subjects. Abdlekawy KS; Donia AM; Elbarbry F Eur J Drug Metab Pharmacokinet; 2017 Jun; 42(3):397-405. PubMed ID: 27294349 [TBL] [Abstract][Full Text] [Related]
8. In vivo CYP3A4 activity, CYP3A5 genotype, and hematocrit predict tacrolimus dose requirements and clearance in renal transplant patients. de Jonge H; de Loor H; Verbeke K; Vanrenterghem Y; Kuypers DR Clin Pharmacol Ther; 2012 Sep; 92(3):366-75. PubMed ID: 22871995 [TBL] [Abstract][Full Text] [Related]
9. Drug interactions with grapefruit juice. Ameer B; Weintraub RA Clin Pharmacokinet; 1997 Aug; 33(2):103-21. PubMed ID: 9260034 [TBL] [Abstract][Full Text] [Related]
10. Increased tacrolimus blood concentration by Beni-Madonna - a new hybrid citrus cultivar categorized as 'Tangor', in a liver transplant patient: likely furanocoumarin-mediated inhibition of CYP3A4 or P-glycoprotein. Ushijima K; Mizuta K; Otomo S; Ogaki K; Sanada Y; Hirata Y; Ihara Y; Urahashi T; Imai Y; Fujimura A Br J Clin Pharmacol; 2018 Dec; 84(12):2933-2935. PubMed ID: 30218442 [TBL] [Abstract][Full Text] [Related]
11. Pomegranate juice does not impair clearance of oral or intravenous midazolam, a probe for cytochrome P450-3A activity: comparison with grapefruit juice. Farkas D; Oleson LE; Zhao Y; Harmatz JS; Zinny MA; Court MH; Greenblatt DJ J Clin Pharmacol; 2007 Mar; 47(3):286-94. PubMed ID: 17322140 [TBL] [Abstract][Full Text] [Related]
12. Progressive decline in tacrolimus clearance after renal transplantation is partially explained by decreasing CYP3A4 activity and increasing haematocrit. de Jonge H; Vanhove T; de Loor H; Verbeke K; Kuypers DR Br J Clin Pharmacol; 2015 Sep; 80(3):548-59. PubMed ID: 26114223 [TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of fruit juices on CYP3A activity. Kim H; Yoon YJ; Shon JH; Cha IJ; Shin JG; Liu KH Drug Metab Dispos; 2006 Apr; 34(4):521-3. PubMed ID: 16415112 [TBL] [Abstract][Full Text] [Related]
14. Pharmacogenetic determinant of the drug interaction between tacrolimus and omeprazole. Zhao W; Fakhoury M; Maisin A; Baudouin V; Storme T; Deschênes G; Jacqz-Aigrain E Ther Drug Monit; 2012 Dec; 34(6):739-41. PubMed ID: 23042259 [TBL] [Abstract][Full Text] [Related]
15. Effects of voriconazole on tacrolimus metabolism in a kidney transplant recipient. Capone D; Tarantino G; Gentile A; Sabbatini M; Polichetti G; Santangelo M; Nappi R; Ciotola A; D'Alessandro V; Renda A; Basile V; Federico S J Clin Pharm Ther; 2010 Feb; 35(1):121-4. PubMed ID: 20175821 [TBL] [Abstract][Full Text] [Related]
16. A Population Pharmacokinetic Model to Predict the Individual Starting Dose of Tacrolimus Following Pediatric Renal Transplantation. Andrews LM; Hesselink DA; van Gelder T; Koch BCP; Cornelissen EAM; Brüggemann RJM; van Schaik RHN; de Wildt SN; Cransberg K; de Winter BCM Clin Pharmacokinet; 2018 Apr; 57(4):475-489. PubMed ID: 28681225 [TBL] [Abstract][Full Text] [Related]
17. Profile of Fork-Tailed Bush Katydid (Orthoptera: Tettigoniidae) Feeding on Fruit of Clementine Mandarins. Cass BN; Kahl HM; Mueller TG; Xi X; Grafton-Cardwell EE; Rosenheim JA J Econ Entomol; 2021 Feb; 114(1):215-224. PubMed ID: 33210704 [TBL] [Abstract][Full Text] [Related]
18. Daily honey consumption does not change CYP3A activity in humans. Fetzner L; Burhenne J; Weiss J; Völker M; Unger M; Mikus G; Haefeli WE J Clin Pharmacol; 2011 Aug; 51(8):1223-32. PubMed ID: 21148046 [TBL] [Abstract][Full Text] [Related]
19. A systematic review of the effect of CYP3A5 genotype on the apparent oral clearance of tacrolimus in renal transplant recipients. Barry A; Levine M Ther Drug Monit; 2010 Dec; 32(6):708-14. PubMed ID: 20864901 [TBL] [Abstract][Full Text] [Related]
20. Tacrolimus concentrations in relation to CYP3A and ABCB1 polymorphisms among solid organ transplant recipients in Korea. Jun KR; Lee W; Jang MS; Chun S; Song GW; Park KT; Lee SG; Han DJ; Kang C; Cho DY; Kim JQ; Min WK Transplantation; 2009 Apr; 87(8):1225-31. PubMed ID: 19384171 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]